Patient Navigation Program Increases Receipt of Colonoscopy

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 3, 2025 -- A patient navigation program is effective for increasing receipt of follow-up colonoscopy among adults with an abnormal stool test result, according to a study published online April 1 in the Annals of Internal Medicine.

Gloria D. Coronado, Ph.D., from the Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues conducted a randomized controlled trial at 32 clinics in a federally qualified health center in Washington state to examine whether a six-topic, telephone-based patient navigation program delivered to persons with an abnormal stool test result increased follow-up colonoscopy completion at one year. Participants were aged 50 to 75 years with an abnormal fecal test result in the previous month; the primary intention-to-treat analysis included 967 patients: 479 in patient navigation and 488 in usual care.

The researchers found that the patient navigation group had higher receipt of follow-up colonoscopy than the usual care group (55.1 versus 42.1 percent). Patients' probability of obtaining a colonoscopy without navigation did not moderate the intervention effect.

"Patient navigation improved rates of colonoscopy follow-up after abnormal fetal immunochemical testing results among patients at a large federally qualified health clinic," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-04 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords